title: The impact of neoadjuvant chemotherapy on the histopathological assessment of thymomas: a clinicopathological correlation of 28 cases treated with a similar regimen.
abstract: BACKGROUND
  Twenty-eight patients treated with neoadjuvant chemotherapy for invasive thymoma are presented.
  
  
  METHODS
  The patients were 16 men and 12 women between the ages of 23 and 75 years (mean = 50.8 years). All patients were treated with a similar modality consisting of three courses of cyclophosphamide, doxorubicin, cisplatin, and prednisone prior to their surgical resection.
  
  
  RESULTS
  Grossly, all tumors were ill-defined invasive masses ranging in size from 5 to 18 cm in greatest dimension. Histological evaluation of the resected tumors showed a gamut of histological features, including necrosis, cystic changes, hemorrhage, histiocytic proliferation, calcifications, and cholesterol cleft granulomas in varying proportions. In addition, we found that some histological types of thymoma appeared to be affected less by neoadjuvant chemotherapy, while others, mainly those tumors with a more prominent lymphocytic component, showed more extensive histological changes.
  
  
  CONCLUSIONS
  Based on the results of this study, it appears that the response to induction chemotherapy in thymomas may be determined by the histological characteristics of the tumor, with treatment-related changes being present predominantly in cases in which the tumor had a prominent lymphocytic component (WHO type B1 and B2), while tumor viability was highest in cases where the histological type corresponded to spindle cell and atypical thymomas (WHO types A and B3, respectively). In addition, it has to be noted that the histological changes attributed to treatment effect may also be seen in untreated tumors thereby not allowing for definitive separation of treated from nontreated thymomas.
authors: Department of Pathology, MD Anderson Cancer Center, Houston, TX 77030, USA. aweissferdt@doctors.org.uk
authors: Annikka
authors: A
authors: Weissferdt
authors: Cesar A
authors: CA
authors: Moran
mesh_terms: D000328:Adult; D000368:Aged; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D017024:Chemotherapy, Adjuvant; D002945:Cisplatin / Q000008:administration & dosage; D003520:Cyclophosphamide / Q000008:administration & dosage; D004317:Doxorubicin / Q000008:administration & dosage; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D009336:Necrosis; D020360:Neoadjuvant Therapy; D009361:Neoplasm Invasiveness; D011241:Prednisone / Q000008:administration & dosage; D013934:Thymectomy; D013945:Thymoma / Q000188:drug therapy* / Q000473:pathology / Q000601:surgery; D013953:Thymus Neoplasms / Q000188:drug therapy* / Q000473:pathology / Q000601:surgery; D016896:Treatment Outcome; D055815:Young Adult
chemical_list: D004317:Doxorubicin; D003520:Cyclophosphamide; D002945:Cisplatin; D011241:Prednisone
references: Lung Cancer. 2004 Jun;44(3):369-79
references: 15140551
references: Am J Clin Oncol. 2006 Aug;29(4):336-44
references: 16891859
references: Lung Cancer. 2004 Apr;44(1):69-77
references: 15013585
references: Ann Oncol. 1993 May;4(5):429-31
references: 8353078
references: Interact Cardiovasc Thorac Surg. 2011 May;12(5):744-7
references: 21172935
references: Curr Opin Oncol. 2012 Mar;24(2):117-22
references: 22143371
references: Ann Thorac Surg. 2008 Feb;85(2):385-9
references: 18222230
references: Gen Thorac Cardiovasc Surg. 2012 Jan;60(1):1-12
references: 22237733
references: Am J Surg Pathol. 2001 Aug;25(8):1086-90
references: 11474295
references: Eur J Cardiothorac Surg. 2011 Mar;39(3):e1-7
references: 21193321
references: Ann Thorac Surg. 2003 Dec;76(6):1866-72; discussion 1872
references: 14667602
references: J Thorac Cardiovasc Surg. 1993 Sep;106(3):543-9
references: 8361199
references: Am J Clin Oncol. 2005 Feb;28(1):5-7
references: 15685027
references: Hematol Oncol Clin North Am. 2008 Jun;22(3):509-26
references: 18514130
references: Am J Clin Pathol. 2012 Mar;137(3):451-61
references: 22338058
references: Cancer. 1991 Aug 15;68(4):706-13
references: 1855170
references: Thorac Surg Clin. 2011 Feb;21(1):107-14, viii
references: 21070992
references: Br J Cancer. 2010 Jun 29;103(1):6-11
references: 20551960
references: Am J Clin Pathol. 2012 Mar;137(3):444-50
references: 22338057
references: J Clin Oncol. 2011 May 20;29(15):2060-5
references: 21502559
references: J Thorac Oncol. 2007 Jan;2(1):73-8
references: 17410014
references: J Thorac Oncol. 2010 Oct;5(10 Suppl 4):S323-6
references: 20859127
references: Ann Thorac Surg. 2005 Jun;79(6):1840-4
references: 15919267
references: Expert Opin Pharmacother. 2005 Jun;6(7):1169-77
references: 15957970